Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Stealth BioTherapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.

Stock Price

$0.3

2022-11-16

Market Capitalization

$18.4 M

2022-11-16

Revenue

$21.1 M

FY, 2019

CreditSafe Score

?
Score changed on Nov 05, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021
Revenue21.1M
General and administrative expense13.4M16.5M22.2M22.3M19.4M19.7M
Operating expense total61.8M79.7M75.3M66.9M
EBIT(61.8M)(79.7M)(75.3M)(45.8M)(48.7M)(46.3M)
EBIT margin, %-217.3%
Interest income799.0K56.8K195.1K988.0K139.0K3.0K
Interest expense3.3M21.4M
Pre tax profit(96.7M)(71.7M)(57.5M)(52.5M)
Net Income(61.0M)(82.9M)(96.7M)(71.7M)(57.5M)(52.5M)

Acquisitions & Subsidiaries

Company nameDateDeal size
LoremDec 23, 2021$40.0M
IpsumJan 18, 2022$30.0M
Lorem IpsumFeb 18, 2022$25.0M
DolorOct 21, 2021$60.0M
Premium Content only available in Craft’s Intelligence Portal
View acquisitions and subsidiaries by company, date, and deal size.
Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm.
Learn more

Footer menu